Literature DB >> 33225581

Long non-coding RNA EWSAT1 promoted metastasis and actin cytoskeleton changes via miR-24-3p sponging in osteosarcoma.

Dewei Shen1, Yize Liu1, Yuexin Liu2, Tao Wang1, Lin Yuan3, Xuyang Huang4, Yong Wang1,5.   

Abstract

Non-coding RNAs are closely associated with tumorigenesis in multiple malignant tumours, including osteosarcoma (OS). Long non-coding RNA Ewing sarcoma-associated transcript 1 (EWSAT1) plays a role in metastasis, and actin cytoskeletal changes in OS remain unclear. In the current study, we showed that EWSAT1 expression was up-regulated in OS and that an elevation in the EWSAT1 expression level was correlated with poor prognosis in patients with OS. Functionally, we showed that knockdown of EWSAT1 suppressed migration and induced actin stress fibre degradation in MNNG/HOS and 143B cells. Moreover, we found that ROCK1 was a key downstream effector in EWSAT1-mediated cell migration and actin stress fibre changes. Furthermore, we demonstrated that ROCK1 and EWSAT1 shared a similar microRNA response element of microRNA-24-3p (miR-24-3p). Moreover, we verified that miR-24-3p suppressed ROCK1 and its mediated migration and actin stress fibres change by direct targeting. EWSAT1 promoted ROCK1-mediated migration and actin stress fibre formation through miR-24-3p sponging. Lastly, through an in vivo study, we demonstrated that EWSAT1 promoted lung metastasis in OS. According to the above-mentioned results, we suggest that EWSAT1 acts as an oncogene and that EWSAT1/miR-24-3p/ROCK1 axial could be a new target in the treatment of OS.
© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  actin stress fibre formation; lncRNAEWSAT1; metastasis; miR-24-3p; osteosarcoma

Mesh:

Substances:

Year:  2020        PMID: 33225581      PMCID: PMC7812296          DOI: 10.1111/jcmm.16121

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.295


  41 in total

1.  Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis.

Authors:  Michelle Marques Howarth; David Simpson; Siu P Ngok; Bethsaida Nieves; Ron Chen; Zurab Siprashvili; Dedeepya Vaka; Marcus R Breese; Brian D Crompton; Gabriela Alexe; Doug S Hawkins; Damon Jacobson; Alayne L Brunner; Robert West; Jaume Mora; Kimberly Stegmaier; Paul Khavari; E Alejandro Sweet-Cordero
Journal:  J Clin Invest       Date:  2014-11-17       Impact factor: 14.808

Review 2.  Regulation of cancer cell motility through actin reorganization.

Authors:  Daisuke Yamazaki; Shusaku Kurisu; Tadaomi Takenawa
Journal:  Cancer Sci       Date:  2005-07       Impact factor: 6.716

3.  Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesis.

Authors:  Dan Li; Xuefeng Liu; Jian Zhou; Jie Hu; Dongdong Zhang; Jing Liu; Yanyan Qiao; Qimin Zhan
Journal:  Hepatology       Date:  2017-03-22       Impact factor: 17.425

Review 4.  MicroRNAs in cancer.

Authors:  Yong Sun Lee; Anindya Dutta
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

5.  miR-24 represses metastasis of human osteosarcoma cells by targeting Ack1 via AKT/MMPs pathway.

Authors:  Zhendong Liu; Zhitao Liu; Yuanjun Zhang; Yan Li; Bo Liu; Kexiang Zhang
Journal:  Biochem Biophys Res Commun       Date:  2017-02-08       Impact factor: 3.575

Review 6.  Long noncoding RNAs usher in a new era in the biology of enhancers.

Authors:  Ulf Andersson Ørom; Ramin Shiekhattar
Journal:  Cell       Date:  2013-09-12       Impact factor: 41.582

7.  miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells.

Authors:  Yong Wang; Wei Zhao; Qin Fu
Journal:  Mol Cell Biochem       Date:  2013-08-22       Impact factor: 3.396

8.  MicroRNAs in the Regulation of MMPs and Metastasis.

Authors:  Mohammed Abba; Nitin Patil; Heike Allgayer
Journal:  Cancers (Basel)       Date:  2014-03-25       Impact factor: 6.639

9.  LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression.

Authors:  Zhen-Zhen Chen; Lan Huang; Ya-Hong Wu; Wen-Jie Zhai; Ping-Ping Zhu; Yan-Feng Gao
Journal:  Nat Commun       Date:  2016-08-24       Impact factor: 14.919

10.  Long non-coding RNA MALAT1 for promoting metastasis and proliferation by acting as a ceRNA of miR-144-3p in osteosarcoma cells.

Authors:  Yong Wang; Yueyang Zhang; Tao Yang; Wei Zhao; Ningning Wang; Pengcheng Li; Xiandong Zeng; Weiguo Zhang
Journal:  Oncotarget       Date:  2017-07-31
View more
  5 in total

Review 1.  Zooming in on Long Non-Coding RNAs in Ewing Sarcoma Pathogenesis.

Authors:  Dave N T Aryee; Valerie Fock; Utkarsh Kapoor; Branka Radic-Sarikas; Heinrich Kovar
Journal:  Cells       Date:  2022-04-08       Impact factor: 7.666

Review 2.  The Landscape of Regulatory Noncoding RNAs in Ewing's Sarcoma.

Authors:  Connor Barrett; Anuj Budhiraja; Vijay Parashar; Mona Batish
Journal:  Biomedicines       Date:  2021-07-31

Review 3.  Clinicopathological and prognostic significance of long non-coding RNA EWSAT1 in human cancers: A review and meta analysis.

Authors:  Jian Wen; Haima Li; Dongdong Li; Xieping Dong
Journal:  PLoS One       Date:  2022-03-14       Impact factor: 3.240

Review 4.  New Insights into the Roles of lncRNAs as Modulators of Cytoskeleton Architecture and Their Implications in Cellular Homeostasis and in Tumorigenesis.

Authors:  Carlos García-Padilla; María Del Mar Muñoz-Gallardo; Estefanía Lozano-Velasco; Juan Manuel Castillo-Casas; Sheila Caño-Carrillo; Virginio García-López; Amelia Aránega; Diego Franco; Virginio García-Martínez; Carmen López-Sánchez
Journal:  Noncoding RNA       Date:  2022-04-13

5.  Long non-coding RNA EWSAT1 promoted metastasis and actin cytoskeleton changes via miR-24-3p sponging in osteosarcoma.

Authors:  Dewei Shen; Yize Liu; Yuexin Liu; Tao Wang; Lin Yuan; Xuyang Huang; Yong Wang
Journal:  J Cell Mol Med       Date:  2020-11-22       Impact factor: 5.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.